Selections of Subjects With Important Changes in Their Cardiac Repolarization Parameters for the Procurement of Skin and Blood Samples

PHASE1CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

August 31, 2011

Conditions
Cardiology: RR / QT
Interventions
DRUG

Erythromycin

4mg/Kg, IV during 20 min once

DRUG

Placebo

4mg/Kg, IV during 20 min once

Trial Locations (1)

92500

BIOTRIAL, Rueil-Malmaison

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Pierre and Marie Curie University

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Ectycell SASU

INDUSTRY